Assyro AI

Orange Book product · Brand (NDA)

ONTRALFY

TIZANIDINE HYDROCHLORIDE

Brand (NDA)NDA 216190RX FIDELITY BIOPHARMA

At a glance

Dec 12, 2024

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 12, 2024

    1 yr 6 mo ago

  2. Today

  3. Patent 12042484 expires

    Listed drug product patent expiration.

    May 07, 2042

    in 16 yr 1 mo

  4. Patent 12263158 expires

    Listed drug product patent expiration.

    May 07, 2042

    in 16 yr 1 mo

Pharmaceutical detail

Active ingredient

TIZANIDINE HYDROCHLORIDE

Strength

EQ 2MG BASE/5ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 216190

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12042484May 07, 2042in 16 yr 1 mo
ProductU-2779
12263158May 07, 2042in 16 yr 1 mo
ProductU-2779
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.